Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
20121.4k citationsDaniel Martín, Maureen G. Maguire et al.Ophthalmologyprofile →
Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
2016539 citationsMaureen G. Maguire, Daniel Martín et al.Ophthalmologyprofile →
Age-related macular degeneration
1988533 citationsNeil M. Bressler, Susan B. Bressler et al.Survey of Ophthalmologyprofile →
Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
2013489 citationsJuan E. Grunwald, Ebenezer Daniel et al.Ophthalmologyprofile →
SENILE MACULAR DEGENERATION: A CASE-CONTROL STUDY
1983469 citationsFrederick L. Ferris, Stuart L. Fine et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Stuart L. Fine
Since
Specialization
Citations
This map shows the geographic impact of Stuart L. Fine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart L. Fine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart L. Fine more than expected).
This network shows the impact of papers produced by Stuart L. Fine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart L. Fine. The network helps show where Stuart L. Fine may publish in the future.
Co-authorship network of co-authors of Stuart L. Fine
This figure shows the co-authorship network connecting the top 25 collaborators of Stuart L. Fine.
A scholar is included among the top collaborators of Stuart L. Fine based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Stuart L. Fine. Stuart L. Fine is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Grunwald, Juan E., Maxwell Pistilli, Ebenezer Daniel, et al.. (2014). Size and growth of geographic atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Investigative Ophthalmology & Visual Science. 55(13). 1649–1649.6 indexed citations
4.
Grunwald, Juan E., Ebenezer Daniel, Gui‐Shuang Ying, et al.. (2013). Geographic atrophy risk factors in participants of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Investigative Ophthalmology & Visual Science. 54(15). 3658–3658.6 indexed citations
Grunwald, Juan E., Ebenezer Daniel, Jiayan Huang, et al.. (2013). Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology. 121(1). 150–161.489 indexed citations breakdown →
Fine, Stuart L., Jeffrey W. Berger, Maureen G. Maguire, & Allen C. Ho. (2000). Age-Related Macular Degeneration. New England Journal of Medicine. 342(7). 483–492.344 indexed citations
11.
Ho, Allen C., David R. Guyer, & Stuart L. Fine. (1998). Macular Hole. Survey of Ophthalmology. 42(5). 393–416.80 indexed citations
Blodi, Barbara A., Mark W. Johnson, J. Donald M. Gass, Stuart L. Fine, & Leonard Joffe. (1990). Purtscher's-like Retinopathy after Childbirth. Ophthalmology. 97(12). 1654–1659.77 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.